Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-10-05
1998-04-28
Spivack, Phyllis G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514415, A61K 31405, A61K 31445
Patent
active
057444820
ABSTRACT:
Methods for the treatment or prevention of migraines comprising administering to a mammal in need thereof a combination of a tachykinin receptor antagonist and a serotonin agonist are disclosed. The administration may be concurrent or sequential, with either of the two activities being administered first.
REFERENCES:
Shepheard et al., Br. J. Pharm., 108(1) 11-12 (1993).
Oliver et al., Arzneim.-Forsch./Drug Res., 44(II) 925-928, Aug. 1994.
Cohen Marlene L.
Johnson Kirk W.
Phebus Lee A.
Boone David E.
Eli Lilly and Company
Gaylo Paul J.
Spivack Phyllis G.
LandOfFree
Serotonin agonist in combination with a tachykinin receptor anta does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Serotonin agonist in combination with a tachykinin receptor anta, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Serotonin agonist in combination with a tachykinin receptor anta will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1532231